These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 18471646

  • 1. Prevention of endophthalmitis by collagen shields presoaked in fourth-generation fluoroquinolones versus by topical prophylaxis.
    Haugen B, Werner L, Romaniv N, Haymore J, Kleinmann G, Mamalis N, Olson RJ.
    J Cataract Refract Surg; 2008 May; 34(5):853-8. PubMed ID: 18471646
    [Abstract] [Full Text] [Related]

  • 2. Topical prophylaxis with moxifloxacin prevents endophthalmitis in a rabbit model.
    Kowalski RP, Romanowski EG, Mah FS, Yates KA, Gordon YJ.
    Am J Ophthalmol; 2004 Jul; 138(1):33-7. PubMed ID: 15234279
    [Abstract] [Full Text] [Related]

  • 3. Laboratory data and statistical evidence in fluoroquinolone study.
    O'Callaghan R, Ohnsman C, Song J.
    J Cataract Refract Surg; 2008 Oct; 34(10):1617-8; author reply 1618. PubMed ID: 18812096
    [No Abstract] [Full Text] [Related]

  • 4. Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model.
    Kowalski RP, Romanowski EG, Mah FS, Yates KA, Gordon YJ.
    Am J Ophthalmol; 2005 Sep; 140(3):497-504. PubMed ID: 16083841
    [Abstract] [Full Text] [Related]

  • 5. Prophylactic gatifloxacin therapy in prevention of bacterial keratitis in a rabbit laser in situ keratomileusis model.
    Slade DS, Friday JW, Snyder RW, Nix DE, Kleinert LB, Patula VB.
    J Cataract Refract Surg; 2007 May; 33(5):888-92. PubMed ID: 17466866
    [Abstract] [Full Text] [Related]

  • 6. Rate of bacterial eradication by ophthalmic solutions of fourth-generation fluoroquinolones.
    Callegan MC, Novosad BD, Ramadan RT, Wiskur B, Moyer AL.
    Adv Ther; 2009 Apr; 26(4):447-54. PubMed ID: 19381523
    [Abstract] [Full Text] [Related]

  • 7. A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections.
    Moss JM, Sanislo SR, Ta CN.
    Ophthalmology; 2009 Aug; 116(8):1498-501. PubMed ID: 19501409
    [Abstract] [Full Text] [Related]

  • 8. Collagen shields as a drug delivery system for the fourth-generation fluoroquinolones.
    Kleinmann G, Larson S, Hunter B, Stevens S, Mamalis N, Olson RJ.
    Ophthalmologica; 2007 Aug; 221(1):51-6. PubMed ID: 17183202
    [Abstract] [Full Text] [Related]

  • 9. Prevention of Staphylococcus aureus endophthalmitis with topical gatifloxacin in a rabbit prophylaxis model.
    de Castro LE, Sandoval HP, Bartholomew LR, Vroman DT, Solomon KD.
    J Ocul Pharmacol Ther; 2006 Apr; 22(2):132-8. PubMed ID: 16722799
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Preventive effect against post-cataract endophthalmitis: drug delivery intraocular lens versus intracameral antibiotics.
    Tsuchiya Y, Kobayakawa S, Tsuji A, Tochikubo T.
    Curr Eye Res; 2008 Oct; 33(10):868-75. PubMed ID: 18853321
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hydrophilic acrylic intraocular lens as a drug-delivery system: Pilot study.
    Kleinmann G, Apple DJ, Chew J, Stevens S, Hunter B, Larson S, Mamalis N, Olson RJ.
    J Cataract Refract Surg; 2006 Apr; 32(4):652-4. PubMed ID: 16698489
    [Abstract] [Full Text] [Related]

  • 14. Prophylactic effect of topical fluoroquinolones in a rabbit model of Staphylococcus aureus endophthalmitis.
    Wu X, Chen H, Jiang H, Xu Y, Liu T, Xu L.
    J Ocul Pharmacol Ther; 2012 Apr; 28(2):186-93. PubMed ID: 22077488
    [Abstract] [Full Text] [Related]

  • 15. Hydrophilic acrylic intraocular lens as a drug-delivery system for fourth-generation fluoroquinolones.
    Kleinmann G, Apple DJ, Chew J, Hunter B, Stevens S, Larson S, Mamalis N, Olson RJ.
    J Cataract Refract Surg; 2006 Oct; 32(10):1717-21. PubMed ID: 17010873
    [Abstract] [Full Text] [Related]

  • 16. Intracameral Vigamox (moxifloxacin 0.5%) is not effective in preventing endophthalmitis in a rabbit model.
    Kodjikian L, Garweg JG.
    Am J Ophthalmol; 2006 Apr; 141(4):777; author reply 777-8. PubMed ID: 16564833
    [No Abstract] [Full Text] [Related]

  • 17. Prophylactic efficacy of ophthalmic quinolones in experimental endophthalmitis in rabbits.
    Wada T, Kozai S, Tajika T, Sakaki H, Suzuki T, Ohashi Y.
    J Ocul Pharmacol Ther; 2008 Jun; 24(3):278-89. PubMed ID: 18462067
    [Abstract] [Full Text] [Related]

  • 18. The successful treatment of gatifloxacin-resistant Staphylococcus aureus keratitis with Zymar (gatifloxacin 0.3%) in a NZW rabbit model.
    Romanowski EG, Mah FS, Yates KA, Kowalski RP, Gordon YJ.
    Am J Ophthalmol; 2005 May; 139(5):867-77. PubMed ID: 15860293
    [Abstract] [Full Text] [Related]

  • 19. Determination of aqueous and vitreous concentration of moxifloxacin 0.5% after delivery via a dissolvable corneal collagen shield device.
    Hariprasad SM, Shah GK, Chi J, Prince RA.
    J Cataract Refract Surg; 2005 Nov; 31(11):2142-6. PubMed ID: 16412929
    [Abstract] [Full Text] [Related]

  • 20. Prophylactic effect of intravenous moxifloxacin in a rabbit model of Staphylococcus epidermidis endophthalmitis.
    Kim JY, Kim SY.
    Invest Ophthalmol Vis Sci; 2011 Mar 25; 52(3):1742-7. PubMed ID: 21169530
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.